Hogy Medical Co.,Ltd. (HGYMF)
USD 24.34
(0.0%)
USD 24.34
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -12.95 Billion JPY | -16804.98% |
| 2023 | -80.42 Million JPY | -135.68% |
| 2022 | -34.12 Million JPY | 81.0% |
| 2021 | -179.61 Million JPY | 13.76% |
| 2020 | -208.27 Million JPY | -1.92% |
| 2019 | -204.34 Million JPY | -6.32% |
| 2018 | -192.2 Million JPY | -36.1% |
| 2017 | -141.22 Million JPY | -111.93% |
| 2016 | 1.18 Billion JPY | 107.05% |
| 2015 | -16.79 Billion JPY | 40.63% |
| 2014 | -28.29 Billion JPY | -27.21% |
| 2013 | -22.24 Billion JPY | -16.25% |
| 2012 | -19.13 Billion JPY | -11.23% |
| 2011 | -17.2 Billion JPY | -9.84% |
| 2010 | -15.65 Billion JPY | -71.55% |
| 2009 | -9.12 Billion JPY | -28.38% |
| 2008 | -7.11 Billion JPY | -127.7% |
| 2007 | -3.12 Billion JPY | 45.33% |
| 2006 | -5.71 Billion JPY | -1927.62% |
| 2005 | -281.72 Million JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -12.95 Billion JPY | -16009.22% |
| 2024 Q1 | -65.43 Million JPY | 18.64% |
| 2024 Q2 | -69.38 Million JPY | -6.03% |
| 2024 Q4 | -12.95 Billion JPY | -16245.99% |
| 2024 Q3 | -79.26 Million JPY | -14.24% |
| 2023 Q3 | -56.89 Million JPY | -23.01% |
| 2023 FY | -80.42 Million JPY | -135.68% |
| 2023 Q4 | -80.42 Million JPY | -41.37% |
| 2023 Q1 | -38.15 Million JPY | -11.8% |
| 2023 Q2 | -46.24 Million JPY | -21.22% |
| 2022 Q4 | -34.12 Million JPY | 76.48% |
| 2022 FY | -34.12 Million JPY | 81.0% |
| 2022 Q3 | -145.09 Million JPY | 13.78% |
| 2022 Q1 | -171.14 Million JPY | 99.15% |
| 2022 Q2 | -168.28 Million JPY | 1.67% |
| 2021 Q2 | -22.04 Billion JPY | -0.02% |
| 2021 Q4 | -20.21 Billion JPY | 2.41% |
| 2021 Q3 | -20.71 Billion JPY | 6.02% |
| 2021 FY | -179.61 Million JPY | 13.76% |
| 2021 Q1 | -22.04 Billion JPY | 2.6% |
| 2020 Q4 | -22.63 Billion JPY | -8.06% |
| 2020 Q1 | -23.76 Billion JPY | -9.54% |
| 2020 FY | -208.27 Million JPY | -1.92% |
| 2020 Q2 | -24.61 Billion JPY | -3.56% |
| 2020 Q3 | -20.94 Billion JPY | 14.93% |
| 2019 Q4 | -21.69 Billion JPY | -1.42% |
| 2019 Q2 | -20.79 Billion JPY | -16.28% |
| 2019 Q1 | -17.88 Billion JPY | 12.45% |
| 2019 Q3 | -21.39 Billion JPY | -2.88% |
| 2019 FY | -204.34 Million JPY | -6.32% |
| 2018 Q3 | -18.74 Billion JPY | 3.68% |
| 2018 Q1 | -18.79 Billion JPY | -23.05% |
| 2018 FY | -192.2 Million JPY | -36.1% |
| 2018 Q4 | -20.42 Billion JPY | -9.01% |
| 2018 Q2 | -19.45 Billion JPY | -3.52% |
| 2017 Q3 | -12.06 Billion JPY | -5.78% |
| 2017 Q2 | -11.4 Billion JPY | 16.37% |
| 2017 Q1 | -13.64 Billion JPY | -23.01% |
| 2017 FY | -141.22 Million JPY | -111.93% |
| 2017 Q4 | -15.27 Billion JPY | -26.58% |
| 2016 Q3 | -10.5 Billion JPY | 5.04% |
| 2016 FY | 1.18 Billion JPY | 107.05% |
| 2016 Q4 | -11.08 Billion JPY | -5.57% |
| 2016 Q2 | -11.06 Billion JPY | 27.21% |
| 2016 Q1 | -15.19 Billion JPY | 9.51% |
| 2015 FY | -16.79 Billion JPY | 40.63% |
| 2015 Q4 | -16.79 Billion JPY | 23.39% |
| 2015 Q1 | -28.02 Billion JPY | 0.94% |
| 2015 Q2 | -24.42 Billion JPY | 12.85% |
| 2015 Q3 | -21.92 Billion JPY | 10.24% |
| 2014 Q4 | -28.29 Billion JPY | -12.82% |
| 2014 Q3 | -25.07 Billion JPY | -1.48% |
| 2014 Q2 | -24.71 Billion JPY | -7.76% |
| 2014 Q1 | -22.93 Billion JPY | -3.12% |
| 2014 FY | -28.29 Billion JPY | -27.21% |
| 2013 FY | -22.24 Billion JPY | -16.25% |
| 2013 Q3 | -20.07 Billion JPY | -0.87% |
| 2013 Q1 | -19.53 Billion JPY | -2.12% |
| 2013 Q2 | -19.9 Billion JPY | -1.87% |
| 2013 Q4 | -22.24 Billion JPY | -10.78% |
| 2012 Q4 | -19.13 Billion JPY | -0.91% |
| 2012 FY | -19.13 Billion JPY | -11.23% |
| 2012 Q3 | -18.95 Billion JPY | 1.96% |
| 2012 Q1 | -18.14 Billion JPY | -5.51% |
| 2012 Q2 | -19.33 Billion JPY | -6.55% |
| 2011 Q3 | -15.57 Billion JPY | 3.78% |
| 2011 Q4 | -17.2 Billion JPY | -10.43% |
| 2011 FY | -17.2 Billion JPY | -9.84% |
| 2011 Q1 | -15.17 Billion JPY | 3.11% |
| 2011 Q2 | -16.18 Billion JPY | -6.69% |
| 2010 Q2 | -13.78 Billion JPY | 0.0% |
| 2010 Q3 | -13.22 Billion JPY | 4.06% |
| 2010 FY | -15.65 Billion JPY | -71.55% |
| 2010 Q4 | -15.65 Billion JPY | -18.38% |
| 2009 Q4 | -9.12 Billion JPY | -20.31% |
| 2009 FY | -9.12 Billion JPY | -28.38% |
| 2009 Q3 | -7.58 Billion JPY | 0.0% |
| 2008 FY | -7.11 Billion JPY | -127.7% |
| 2007 FY | -3.12 Billion JPY | 45.33% |
| 2006 FY | -5.71 Billion JPY | -1927.62% |
| 2005 FY | -281.72 Million JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | 2701343.247% |
| Ansell Limited | -54.99 Million USD | -23457.704% |
| Ansell Limited | -55.1 Million USD | -23413.612% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | -36.49 Million USD | -35402.538% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | -12326972.748% |
| Psykey, Inc. | 634.59 Thousand USD | 2041723.529% |
| ConvaTec Group Plc | 1.2 Billion USD | 1179.125% |
| ConvaTec Group Plc | 1.2 Billion USD | 1177.601% |
| Encision Inc. | 1.29 Million USD | 1003901.834% |
| Golden Valley Development, Inc | - USD | Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 561277.485% |
| Innovative MedTech Inc. | 1.76 Million USD | 734260.804% |
| LifePoint, Inc. | -3.26 Million USD | -396833.721% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 264282.691% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 599359.944% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | -29918614.207% |
| Reflect Scientific, Inc. | -1.03 Million USD | -1251316.247% |
| SmileDirectClub, Inc. | 778.67 Million USD | 1763.848% |
| Sector 10, Inc. | 163 Thousand USD | 7948566.258% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | -3002.83% |
| SheerVision, Inc. | 57.34 Thousand USD | 22591601.16% |
| United Health Products, Inc. | 660.56 Thousand USD | 1961439.391% |
| Vasamed, Inc. | 22.12 Thousand USD | 58566233.261% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 492495.35% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 1677732.047% |